Health Condition 1: I739- Peripheral vascular disease, unspecified
Conditions
Interventions
Intervention1: The experimental group will receive nurse-led lifestyle modification program: The experimental group will receive a nurse-led lifestyle modification program in addition to the standard
Sponsors
None listed
Eligibility
Inclusion criteria
Inclusion criteria: Participants included in the study will be those who have undergone percutaneous coronary intervention (PCI) and are willing to participate, are above 18 years of age, can understand either Hindi or English, are accessible via telephone, and have a SYNTAX score of 22 or higher.
Exclusion criteria
Exclusion criteria: Patient who needs emergency cardiac surgery post PCI. Patient who are admitted for MACE and going for PCI.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary CLINICAL OUTCOMES PART-1: MACE check list Myocardial infarction (MI), stroke/cerebrovascular event, hospital readmission, revascularization, cardiovascular death and mortality (all-cause) PART-2: Novel haematological indices Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), monocyte-to-HDL ratio (MHR), high-sensitivity C-reactive protein (hs-CRP), NT-Pro (BNP), and the triglyceride-glucose (TyG) Index. Timepoint: Every week for 1 month | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes Ejection fraction & blood pressure Timepoint: At baseline & after 1 month. | — |
Countries
India
Contacts
Public ContactNipin Kalal
AIIMS,Jodhpur
Outcome results
None listed